DaVita Inc. (DVA) Stock Analysis - Quarterly Financial Performance

Quatable Logo
DVA

DaVita Inc.|Healthcare

DaVita Inc. (DVA) Investment Analysis

320 words • Includes news sentiment

AI + News
Revenue QoQ
+1.2%
Revenue YoY
+4.8%
Operating Margin
14.6%
Growth Streak
2 Qtrs

Comprehensive Analysis for DVA

In Q4 2025, DaVita Inc. reported a solid financial performance with revenue growth of 1.2% on a quarterly basis and 4.8% year-over-year. Despite this, their profit margin contracted by -6.57% QoQ and -6.7% YoY, which may be concerning for some investors. However, DaVita's operating margin remained strong at 14.57%, exceeding the sector average of 14.5%. Their net margin also improved slightly from the previous quarter to 5.8%.

Looking ahead, DaVita's robust earnings and raised guidance for 2026, along with their recent strategic investments, indicate a positive outlook for the company. They have consecutively grown in two consecutive quarters, showing improvement in their financial performance. However, it is important to note that their profit growth rate has been declining over the past three years, with no significant increase recorded in their 3-year Profit CAGR.

The recent news sentiment surrounding DaVita is positive, as they have beaten expectations and estimates in Q4, with adjusted earnings of $3.40 per share. Furthermore, they have raised their guidance for 2026, projecting adjusted earnings of $13.60-$15.00 per share. This suggests that investors should take a closer look at DaVita's growth prospects and consider investing in the company based on these positive catalysts.

Despite the strong financial performance and positive news sentiment, there are still potential concerns for investors to consider. The declining profit growth rate over the past three years may indicate that the company is facing challenges in maintaining its profitability. Additionally, there are no identified risk factors that could negatively impact DaVita's financial performance.

In conclusion, DaVita Inc. (DVA) presents a promising investment opportunity for those looking to capitalize on the healthcare sector's growth. With solid revenue and earnings growth, robust operating and net margins, and positive news sentiment, investors should carefully consider adding this stock to their portfolio. However, it is essential to monitor the company's profit growth rate and keep an eye on any potential risks that may arise in the future.

This investment analysis for DaVita Inc. (DVA) combines quarterly financial data, AI-powered news sentiment analysis, and sector comparisons. Analysis generated by Quatable AI • Data as of Feb 8, 2026

Stock Price Trend

Financial Performance

Performance Rankings

ComparisonRev.
QoQ
Rev.
YoY
Profit
QoQ
Profit
YoY
S&P 500(503)#132#188#115#172
Healthcare(60)#15#20#16#27

Multi-Metric Performance Analysis